QuickView for ERG11;jsessionid=EE974F5754519FE226755A454D5421E2;jsessionid=E42A117A988A6F13D9F60985F4198D5F;jsessionid=05B4210A270FDEAAFF7FC16B7DD3C718;jsessionid=B223534136F1404331B07423A134BDD5;jsessionid=EB4B3A93A0E4AD02C5B8DEAD36333008 (gene)

1. Inhibitory effect of magnetic iron-oxide nanoparticles on the pattern of expression of lanosterol 14…
2. Strategies of targeting CYP51 for IFIs therapy: Emerging prospects, opportunities and challenges.
3. Characterization of Prototheca CYP51/ERG11 as a possible target for therapeutic drugs.
4. Male germ cell-specific knockout of cholesterogenic cytochrome P450 lanosterol 14α-demethylase (Cyp5…
5. Synthesis of obtusifoliol and analogues as CYP51 substrates.

There were no clinical trials for ERG11;jsessionid=EE974F5754519FE226755A454D5421E2;jsessionid=E42A117A988A6F13D9F60985F4198D5F;jsessionid=05B4210A270FDEAAFF7FC16B7DD3C718;jsessionid=B223534136F1404331B07423A134BDD5;jsessionid=EB4B3A93A0E4AD02C5B8DEAD36333008